pentetic acid has been researched along with Neoplasms in 109 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The increased expression of the neurotensin (NT) receptor NTS1 by different cancer cells, such as pancreatic adenocarcinoma and ductal breast cancer cells, as compared to normal epithelium, offers the opportunity to target these tumors with radiolabeled neurotensin analogues for diagnostic or therapeutic purposes." | 3.75 | Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors. ( Abdelhak, J; Alshoukr, F; Barbet, J; Burg, S; Gruaz-Guyon, A; Maes, V; Pelaprat, D; Raguin, O; Rosant, C; Sarda, L; Tourwé, D, 2009) |
| "Thirteen (13) patients with liver neuroendocrine carcinomas metastases, positive for somatostatin receptors, confirmed by scintigraphy were infused with 4070-7030 MBq per session of In-111-octreotide after selective hepatic catheterization, exploiting the catastrophic activity of Indium Auger and Internal Conversion electron emission on cell DNA." | 3.73 | Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings. ( Dimitriou, P; Dimitropoulos, N; Hatzioannou, A; Kontogeorgakos, D; Koutoulidis, V; Limouris, GS; Lyra, M; Mourikis, D; Papanikolos, G; Stravaka, A; Vlahos, L, 2005) |
| " This report presents the results of pharmacokinetic and dosimetric studies performed in 24 patients with different tumours." | 2.69 | Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients. ( Chinol, M; Cremonesi, M; Ferrari, M; Grana, C; Paganelli, G; Prisco, G; Robertson, C; Stabin, MG; Tosi, G, 1999) |
| "In developed countries, cancer is the second leading cause of death, being only surpassed by cardiovascular diseases." | 2.47 | Radiometallated peptides for molecular imaging and targeted therapy. ( Correia, JD; Paulo, A; Raposinho, PD; Santos, I, 2011) |
| "The vast majority of human tumors seem to over-express the one or the other of five distinct hSSTR subtype receptors." | 2.41 | Experience with indium-111 and yttrium-90-labeled somatostatin analogs. ( Andreae, F; Angelberger, P; Burggasser, G; Dudczak, R; Füger, B; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Pangerl, T; Patri, P; Raderer, M; Traub, T; Virgolini, I, 2002) |
| "The value of SRI in patients with other tumors, such as breast cancer or malignant lymphomas, or in patients with granulomatous diseases has to be established." | 2.41 | Peptide receptor imaging and therapy. ( de Jong, M; Krenning, EP; Kwekkeboom, D, 2000) |
| "Nanoparticles' uptake by cancer cells upon reaching the tumor microenvironment is often the rate-limiting step in cancer nanomedicine." | 1.91 | Novel Strategy to Drive the Intracellular Uptake of Lipid Nanoparticles for Photodynamic Therapy. ( Bu, J; Chen, J; Cheng, MHY; Ding, L; Guidolin, K; Ho, T; Makky, A; Valic, M; Yau, J; Zheng, G; Zheng, M, 2023) |
| "To visualize whole cancerous region including hypoxic cancer without radiation exposure, we developed meglumine-gadopentetate-glucose solution for 7." | 1.62 | Whole cancer-region enhancement using meglumine-gadopentetate-glucose solution and 7.0-T magnetic resonance imaging. ( Enomoto, T; Hagiwara, O; Matsukiyo, H; Moriyama, H; Sato, E; Sato, Y; Takeda, K; Watanabe, M; Yoshida, R; Yoshida, S; Yoshioka, K, 2021) |
| "Among different cytokines used for cancer immunotherapy, interleukin-12 (IL-12) has shown great ability as a powerful antitumor and antiangiogenic agent." | 1.43 | Enhanced Delivery of Plasmid Encoding Interleukin-12 Gene by Diethylene Triamine Penta-Acetic Acid (DTPA)-Conjugated PEI Nanoparticles. ( Dehshahri, A; Keykhaee, M; Khalvati, B; Sadeghpour, H; Sheikhsaran, F, 2016) |
| "Colon26 tumors inoculated in the right shoulder were clearly visualized by SPECT 24h after administration." | 1.43 | Feasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imaging. ( Homma, T; Kanazaki, K; Makino, A; Ono, M; Saji, H; Sano, K; Takahashi, A; Yamauchi, F, 2016) |
| "The results also showed a good anticancer activity for 99mTc-DTPA-Methionine." | 1.39 | A comparative study of two novel nanosized radiolabeled analogues of methionine for SPECT tumor imaging. ( Aghasadeghi, MR; Alavidjeh, MS; Amanlou, M; Ardestani, MS; Daha, FJ; Ebrahimi, SE; Ghorbani, M; Khosroshahi, AG; Mousavi, L; Pouriayevali, MH; Sabzevari, O; Sadat, SM, 2013) |
| "EGFR is over-expressed in several solid tumors including breast, prostate, pancreas, and lung cancers and is correlated to the metastatic potential of the tumor." | 1.37 | Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent. ( Alavi, A; Berezov, A; Greene, MI; Murali, R; Ponde, DE; Su, Z; Zhang, H, 2011) |
| "U-87MG and BMG tumors saturated at approximately 2000 +/- 280 nmol/kg of (99m)Tc-DTPA-bis(Met)." | 1.36 | Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine). ( Chuttani, K; Goel, V; Hazari, PP; Kumar, N; Mishra, AK; Sharma, R; Shukla, G, 2010) |
| "Tumors were clearly visualized 1 day after injecting 3." | 1.36 | PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab. ( Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK; Regino, CA; Szajek, LP; Wong, KJ, 2010) |
| "In mice bearing LS-174T, PC-3, or A431 tumors, the tumor uptake at 3 d was 34." | 1.36 | Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma. ( Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK, 2010) |
| "To improve the targeting to tumors expressing the cholecystokinin receptor subtype 2 (CCK2R) with limited kidney uptake, we synthesized a novel cholecystokinin C-terminal tetrapeptide (CCK4)-based derivative conjugated to an original bipyridine-chelator (BPCA), 111In-BPCA-(Ahx)2-CCK4." | 1.36 | Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation. ( Benoist, E; Brillouet, S; Courbon, F; Delord, JP; Dorbes, S; Mestre-Voegtlé, B; Picard, C; Poirot, M; Silvente-Poirot, S, 2010) |
| "Tracer kinetics in tumors and nontumor tissues and tumor-to-background ratios were described by region-of-interest analysis and standardized uptake values (SUVs)." | 1.33 | Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide. ( Herz, M; Meisetschläger, G; Poethko, T; Scheidhauer, K; Schottelius, M; Schwaiger, M; Stahl, A; Wester, HJ; Wolf, I, 2006) |
| "In 21 patients with SSTR-expressing tumors, the semiquantitative region-of-interest analysis showed that (99m)Tc-TOC achieved higher tumor-to-normal tissue ratios than (111)In-OCT." | 1.32 | An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. ( Decristoforo, C; Donnemiller, E; Gabriel, M; Mather, SJ; Moncayo, R; Ulmer, H; Watfah Rychlinski, C, 2003) |
| "In K1735-M2 and CT-26 tumors, a single treatment with IA-NP-(90)Y (14." | 1.32 | A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles. ( Bednarski, MD; Choi, HS; Chu, P; Danthi, SN; Dechene, N; Doede, T; Knox, SJ; Lee, DY; Li, L; Ning, S; Pease, J; Shen, Z; Wartchow, CA, 2004) |
| "ACTH-secreting tumors were localized in 13 patients and were occult in four." | 1.32 | The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. ( Carrasquillo, JA; Chen, CC; Ilias, I; Nieman, LK; Pacak, K; Whatley, M, 2004) |
| "Int." | 1.31 | Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. ( Bernard, HF; Breeman, WA; de Jong, M; Krenning, EP; Mooij, CM; Schaar, M; Schmidt, MA; Srinivasan, A; van Hagen, PM, 2000) |
| "The uptake in the lung tumors was at an intermediate level (18." | 1.31 | Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. ( Glass, D; Harrington, KJ; Mohammadtaghi, S; Peters, AM; Stewart, JS; Uster, PS; Vile, RG, 2001) |
| "For deep-lying tumors the NaI(TI) detector was superior, whereas the CdTe detector was best suited for superficial tumors with a high activity concentration in the underlying tissue." | 1.30 | Evaluation of three gamma detectors for intraoperative detection of tumors using 111In-labeled radiopharmaceuticals. ( Ahlman, H; Benjegård, SA; Bernhardt, P; Forssell-Aronsson, E; Sauret, V; Wängberg, B, 1999) |
| " Because renal excretion is the major variable determining the pharmacokinetics of this drug, a dosing formula based on glomerular filtration rate (GFR) has been proposed and is being increasingly used in carboplatin dosing." | 1.29 | Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute. ( Bishop, JF; Hicks, R; Johnston, VK; Millward, MJ; Rischin, D; Stokes, KH; Toner, GC; Webster, LK, 1996) |
| "Somatostatin receptor-positive human tumors can be detected using radioiodinated analogues of somatostatin, both in vitro and in vivo." | 1.28 | [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. ( Albert, R; Bakker, WH; Breeman, WA; Bruns, C; Hofland, LJ; Koper, JW; Marbach, P; Pless, J; Pralet, D; Stolz, B, 1991) |
| " In addition, pharmacokinetic studies assessed the ability of C46-GYK-DTPA labeled with 111In to localize to and image human tumor xenografts in nude mice." | 1.28 | Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate. ( D'Aleo, CJ; Davis, WL; Gilman, SC; Lopes, AD; Rosenstraus, MJ, 1990) |
| " The MR examination included various plain T1 and T2 weighted spin echo sequences as well as T1 weighted examinations after intravenous application of Gadolinium-DTPA ("Magnevist", Schering AG) in a dosage of 0." | 1.28 | [Gadolinium-DTPA in magnetic resonance tomography. Clinical use--indications]. ( Imhof, H; Kramer, J; Prayer, L; Stiglbauer, R; Wimberger, D, 1989) |
| "In 11 patients with various primary tumors, local recurrences or metastases [colorectal carcinoma (n = 7), ovarian carcinoma (n = 2), papillary thyroid carcinoma (n = 1), undifferentiated carcinoma of the lung (n = 1)], immunoscintigraphy (IS) was carried out using 111In-DTPA-labeled F(ab')2 fragments of various MAbs (anti-CEA, OC 125, anti-hTG) and planar and tomographic imaging were compared intra-individually." | 1.27 | [Immunoscintigraphy using 111In-DTPA-labeled monoclonal antibodies: comparison with ECT and planar scintigraphy]. ( Baum, RP; Brandhorst, I; Frohn, J; Halbsguth, A; Happ, J; Hör, G; Lochner, B; Weimer, B, 1987) |
| "Rhenium-186 has been theoretically determined to be among the best therapy radiolabels due to its unique half-life, particulate and gamma emissions and chelation properties." | 1.27 | Radiolabeled biomolecules with 186Re: potential for radioimmunotherapy. ( Quadri, SM; Wessels, BW, 1986) |
| "A total of 14 cancer patients were studied, nine with identifiable sites of metastatic disease from colorectal [8], pancreatic [2], ovarian [3], or small cell lung [1] primaries." | 1.27 | Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients. ( Childs, RL; Doherty, PW; Griffin, TW; Hnatowich, DJ; Kosciuczyk, C; Mattis, JA; Rusckowski, M; Shealy, D, 1985) |
| "In all, 39 patients with advanced cancer were treated at doses of 2." | 1.27 | Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056). ( Groth, S; Hansen, HH; Hansen, SW; Nissen, MH; Rørth, M; Sørensen, JB, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (17.43) | 18.7374 |
| 1990's | 30 (27.52) | 18.2507 |
| 2000's | 32 (29.36) | 29.6817 |
| 2010's | 20 (18.35) | 24.3611 |
| 2020's | 8 (7.34) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Xu, R | 1 |
| Chi, W | 1 |
| Zhao, Y | 1 |
| Tang, Y | 1 |
| Jing, X | 1 |
| Wang, Z | 2 |
| Zhou, Y | 1 |
| Shen, Q | 1 |
| Zhang, J | 1 |
| Yang, Z | 1 |
| Dang, D | 1 |
| Meng, L | 1 |
| Margalik, DA | 1 |
| Chen, J | 2 |
| Ho, T | 2 |
| Ding, L | 2 |
| Dhaliwal, A | 1 |
| Doria, AS | 1 |
| Zheng, G | 2 |
| Guidolin, K | 1 |
| Makky, A | 1 |
| Valic, M | 1 |
| Bu, J | 1 |
| Zheng, M | 1 |
| Cheng, MHY | 1 |
| Yau, J | 1 |
| Tang, S | 1 |
| Li, G | 1 |
| Zhang, H | 2 |
| Bao, Y | 1 |
| Wu, X | 1 |
| Yan, R | 1 |
| Jin, Y | 1 |
| Hosseini, SM | 1 |
| Mohammadnejad, J | 1 |
| Yousefnia, H | 1 |
| Alirezapour, B | 1 |
| Rezayan, AH | 1 |
| Zhang, Y | 1 |
| Liu, D | 1 |
| Qiao, B | 1 |
| Luo, Y | 1 |
| Yang, C | 1 |
| Zhang, L | 1 |
| Cao, Y | 1 |
| Ran, H | 1 |
| Luca, S | 1 |
| Verdoliva, V | 1 |
| Saviano, M | 1 |
| Sato, E | 1 |
| Yoshida, S | 1 |
| Takeda, K | 1 |
| Yoshida, R | 1 |
| Sato, Y | 1 |
| Yoshioka, K | 1 |
| Moriyama, H | 1 |
| Hagiwara, O | 1 |
| Matsukiyo, H | 1 |
| Enomoto, T | 1 |
| Watanabe, M | 1 |
| Yamamoto, T | 1 |
| Kabus, S | 1 |
| Kanazaki, K | 2 |
| Sano, K | 3 |
| Makino, A | 2 |
| Takahashi, A | 2 |
| Deguchi, J | 1 |
| Ohashi, M | 1 |
| Temma, T | 1 |
| Ono, M | 2 |
| Saji, H | 3 |
| Hazari, PP | 2 |
| Prakash, S | 1 |
| Meena, VK | 1 |
| Jaswal, A | 1 |
| Khurana, H | 1 |
| Mishra, SK | 1 |
| Bhonsle, HK | 1 |
| Singh, L | 1 |
| Mishra, AK | 3 |
| Li, JJ | 1 |
| Lan, KL | 1 |
| Chang, SF | 1 |
| Chen, YF | 1 |
| Tsai, WC | 1 |
| Chiang, PH | 1 |
| Lin, MH | 1 |
| Fischer, WB | 1 |
| Shih, YS | 1 |
| Yen, SH | 1 |
| Liu, RS | 1 |
| Tsay, YG | 1 |
| Wang, HE | 1 |
| Chang, CA | 1 |
| Dehshahri, A | 1 |
| Sadeghpour, H | 1 |
| Keykhaee, M | 1 |
| Khalvati, B | 1 |
| Sheikhsaran, F | 1 |
| Yamauchi, F | 1 |
| Homma, T | 1 |
| Stammes, MA | 1 |
| Knol-Blankevoort, VT | 1 |
| Cruz, LJ | 1 |
| Feitsma, HR | 1 |
| Mezzanotte, L | 1 |
| Cordfunke, RA | 1 |
| Sinisi, R | 1 |
| Dubikovskaya, EA | 1 |
| Maeda, A | 1 |
| DaCosta, RS | 1 |
| Bierau, K | 1 |
| Chan, A | 1 |
| Kaijzel, EL | 1 |
| Snoeks, TJ | 1 |
| van Beek, ER | 1 |
| Löwik, CW | 1 |
| Hagimori, M | 1 |
| Hatabe, E | 1 |
| Miyazaki, H | 1 |
| Sasaki, H | 1 |
| Mukai, T | 1 |
| Xiong, QF | 1 |
| Chen, Y | 1 |
| Alshoukr, F | 1 |
| Rosant, C | 1 |
| Maes, V | 1 |
| Abdelhak, J | 1 |
| Raguin, O | 1 |
| Burg, S | 1 |
| Sarda, L | 1 |
| Barbet, J | 1 |
| Tourwé, D | 1 |
| Pelaprat, D | 1 |
| Gruaz-Guyon, A | 1 |
| Müssig, K | 1 |
| Oksüz, MO | 1 |
| Pfannenberg, C | 1 |
| Adam, P | 1 |
| Zustin, J | 1 |
| Beckert, S | 1 |
| Petersenn, S | 1 |
| Shukla, G | 1 |
| Goel, V | 1 |
| Chuttani, K | 2 |
| Kumar, N | 1 |
| Sharma, R | 1 |
| Nayak, TK | 2 |
| Regino, CA | 1 |
| Wong, KJ | 1 |
| Milenic, DE | 2 |
| Garmestani, K | 2 |
| Baidoo, KE | 2 |
| Szajek, LP | 1 |
| Brechbiel, MW | 4 |
| Brillouet, S | 1 |
| Dorbes, S | 1 |
| Courbon, F | 1 |
| Picard, C | 1 |
| Delord, JP | 1 |
| Benoist, E | 1 |
| Poirot, M | 1 |
| Mestre-Voegtlé, B | 1 |
| Silvente-Poirot, S | 1 |
| Kakkar, D | 1 |
| Tiwari, AK | 1 |
| Kaul, A | 1 |
| Singh, H | 1 |
| Josan, JS | 1 |
| De Silva, CR | 1 |
| Yoo, B | 1 |
| Lynch, RM | 1 |
| Pagel, MD | 1 |
| Vagner, J | 1 |
| Hruby, VJ | 1 |
| Park, D | 1 |
| Don, AS | 1 |
| Massamiri, T | 1 |
| Karwa, A | 1 |
| Warner, B | 1 |
| MacDonald, J | 1 |
| Hemenway, C | 1 |
| Naik, A | 1 |
| Kuan, KT | 1 |
| Dilda, PJ | 1 |
| Wong, JW | 1 |
| Camphausen, K | 1 |
| Chinen, L | 1 |
| Dyszlewski, M | 1 |
| Hogg, PJ | 1 |
| Correia, JD | 1 |
| Paulo, A | 1 |
| Raposinho, PD | 1 |
| Santos, I | 1 |
| Ponde, DE | 1 |
| Su, Z | 1 |
| Berezov, A | 1 |
| Alavi, A | 1 |
| Greene, MI | 1 |
| Murali, R | 1 |
| Maecke, HR | 2 |
| Reubi, JC | 5 |
| Laverman, P | 1 |
| Sosabowski, JK | 1 |
| Boerman, OC | 1 |
| Oyen, WJ | 1 |
| Khosroshahi, AG | 1 |
| Amanlou, M | 1 |
| Sabzevari, O | 1 |
| Daha, FJ | 1 |
| Aghasadeghi, MR | 1 |
| Ghorbani, M | 1 |
| Ardestani, MS | 1 |
| Alavidjeh, MS | 1 |
| Sadat, SM | 1 |
| Pouriayevali, MH | 1 |
| Mousavi, L | 1 |
| Ebrahimi, SE | 1 |
| Virgolini, I | 2 |
| Traub, T | 1 |
| Novotny, C | 1 |
| Leimer, M | 2 |
| Füger, B | 1 |
| Li, SR | 1 |
| Patri, P | 1 |
| Pangerl, T | 1 |
| Angelberger, P | 2 |
| Raderer, M | 2 |
| Burggasser, G | 1 |
| Andreae, F | 1 |
| Kurtaran, A | 2 |
| Dudczak, R | 1 |
| Weiner, RE | 1 |
| Thakur, ML | 1 |
| Hosseinkhani, H | 1 |
| Aoyama, T | 1 |
| Ogawa, O | 1 |
| Tabata, Y | 2 |
| Gabriel, M | 1 |
| Decristoforo, C | 1 |
| Donnemiller, E | 1 |
| Ulmer, H | 1 |
| Watfah Rychlinski, C | 1 |
| Mather, SJ | 1 |
| Moncayo, R | 1 |
| ROSENTHAL, MW | 2 |
| MARKLEY, JF | 2 |
| LINDENBAUM, A | 2 |
| Wen, X | 1 |
| Wu, QP | 1 |
| Ke, S | 1 |
| Wallace, S | 1 |
| Charnsangavej, C | 1 |
| Huang, P | 1 |
| Liang, D | 1 |
| Chow, D | 1 |
| Li, C | 1 |
| Ke, CY | 2 |
| Mathias, CJ | 2 |
| Green, MA | 2 |
| Khawli, LA | 1 |
| Alauddin, MM | 1 |
| Hu, P | 1 |
| Epstein, AL | 1 |
| Li, L | 1 |
| Wartchow, CA | 1 |
| Danthi, SN | 1 |
| Shen, Z | 1 |
| Dechene, N | 1 |
| Pease, J | 1 |
| Choi, HS | 1 |
| Doede, T | 1 |
| Chu, P | 1 |
| Ning, S | 1 |
| Lee, DY | 1 |
| Bednarski, MD | 1 |
| Knox, SJ | 1 |
| Pacak, K | 1 |
| Ilias, I | 1 |
| Chen, CC | 1 |
| Carrasquillo, JA | 1 |
| Whatley, M | 1 |
| Nieman, LK | 1 |
| Bernard, B | 1 |
| Capello, A | 1 |
| van Hagen, M | 1 |
| Breeman, W | 1 |
| Srinivasan, A | 3 |
| Schmidt, M | 1 |
| Erion, J | 2 |
| van Gameren, A | 1 |
| Krenning, E | 1 |
| de Jong, M | 6 |
| Forssell-Aronsson, E | 3 |
| Bernhardt, P | 2 |
| Nilsson, O | 2 |
| Tisell, LE | 1 |
| Wängberg, B | 3 |
| Ahlman, H | 3 |
| Kwekkeboom, DJ | 4 |
| Mueller-Brand, J | 1 |
| Paganelli, G | 2 |
| Anthony, LB | 2 |
| Pauwels, S | 1 |
| Kvols, LK | 1 |
| O'dorisio, TM | 1 |
| Valkema, R | 3 |
| Bodei, L | 1 |
| Chinol, M | 2 |
| Krenning, EP | 8 |
| Limouris, GS | 1 |
| Dimitropoulos, N | 1 |
| Kontogeorgakos, D | 1 |
| Papanikolos, G | 1 |
| Koutoulidis, V | 1 |
| Hatzioannou, A | 1 |
| Mourikis, D | 1 |
| Lyra, M | 1 |
| Dimitriou, P | 1 |
| Stravaka, A | 1 |
| Vlahos, L | 1 |
| Berndorff, D | 1 |
| Borkowski, S | 1 |
| Sieger, S | 1 |
| Rother, A | 1 |
| Friebe, M | 1 |
| Viti, F | 1 |
| Hilger, CS | 1 |
| Cyr, JE | 1 |
| Dinkelborg, LM | 1 |
| Boswell, CA | 1 |
| Meisetschläger, G | 1 |
| Poethko, T | 1 |
| Stahl, A | 1 |
| Wolf, I | 1 |
| Scheidhauer, K | 1 |
| Schottelius, M | 1 |
| Herz, M | 1 |
| Wester, HJ | 1 |
| Schwaiger, M | 1 |
| Lewis, I | 1 |
| Albert, R | 2 |
| Kneuer, R | 1 |
| Pless, J | 2 |
| Simeon, C | 1 |
| Kerrad, S | 1 |
| Hoyer, D | 1 |
| Bruns, C | 3 |
| Liu, J | 1 |
| Ohta, S | 1 |
| Sonoda, A | 1 |
| Yamada, M | 2 |
| Yamamoto, M | 1 |
| Nitta, N | 1 |
| Murata, K | 1 |
| de Korte, MA | 1 |
| de Vries, EG | 1 |
| Lub-de Hooge, MN | 1 |
| Jager, PL | 1 |
| Gietema, JA | 1 |
| van der Graaf, WT | 1 |
| Sluiter, WJ | 1 |
| van Veldhuisen, DJ | 1 |
| Suter, TM | 1 |
| Sleijfer, DT | 1 |
| Perik, PJ | 1 |
| Wesbey, GE | 1 |
| Engelstad, BL | 1 |
| Brasch, RC | 1 |
| Carr, DH | 1 |
| Lamberts, SW | 2 |
| Visser, TJ | 2 |
| Bakker, WH | 4 |
| Kooij, PP | 3 |
| Rubin, PA | 1 |
| Bilyk, JR | 1 |
| Shore, JW | 1 |
| Sutula, FC | 1 |
| Cheng, HM | 1 |
| Westlin, JE | 3 |
| Ahlström, H | 1 |
| Ylä-Jääski, J | 2 |
| Oberg, K | 1 |
| Nilsson, S | 3 |
| van Osdol, WW | 1 |
| Sung, C | 1 |
| Dedrick, RL | 1 |
| Weinstein, JN | 1 |
| Arnberg, H | 1 |
| Husin, S | 1 |
| Li, S | 1 |
| Yang, Q | 1 |
| Neuhold, N | 1 |
| Kaserer, K | 1 |
| Peck-Radosavljevic, M | 1 |
| Scheithauer, W | 1 |
| Niederle, B | 1 |
| Eichler, HG | 1 |
| Valent, P | 1 |
| Steens, J | 1 |
| Cleton, FJ | 1 |
| Pauwels, EK | 1 |
| Millward, MJ | 1 |
| Webster, LK | 1 |
| Toner, GC | 1 |
| Bishop, JF | 1 |
| Rischin, D | 1 |
| Stokes, KH | 1 |
| Johnston, VK | 1 |
| Hicks, R | 1 |
| Harrison, KA | 1 |
| Tempero, MA | 1 |
| Uno, K | 1 |
| Kuyama, J | 1 |
| Uchida, Y | 1 |
| Sakata, S | 1 |
| Kitakata, Y | 1 |
| Waser, B | 1 |
| Schaer, JC | 1 |
| Laederach, U | 1 |
| Schmidt, MA | 2 |
| Bugaj, JE | 1 |
| Hosono, M | 1 |
| Cremonesi, M | 1 |
| Ferrari, M | 1 |
| Stabin, MG | 1 |
| Grana, C | 1 |
| Prisco, G | 1 |
| Robertson, C | 1 |
| Tosi, G | 1 |
| Espenan, GD | 1 |
| Nelson, JA | 1 |
| Fisher, DR | 1 |
| Diaco, DS | 1 |
| McCarthy, KE | 1 |
| Maloney, TJ | 1 |
| Woltering, EA | 1 |
| Schörner, W | 1 |
| Lang, P | 1 |
| Bittner, R | 1 |
| Felix, R | 2 |
| Jones-Bey, H | 1 |
| Benjegård, SA | 2 |
| Sauret, V | 1 |
| Kälkner, KM | 1 |
| van Hagen, PM | 1 |
| Breeman, WA | 4 |
| Bernard, HF | 1 |
| Schaar, M | 1 |
| Mooij, CM | 1 |
| Kwekkeboom, D | 1 |
| Ong, GL | 1 |
| Elsamra, SE | 1 |
| Goldenberg, DM | 1 |
| Mattes, MJ | 1 |
| Gabizon, AA | 1 |
| Harrington, KJ | 1 |
| Mohammadtaghi, S | 1 |
| Uster, PS | 1 |
| Glass, D | 1 |
| Peters, AM | 1 |
| Vile, RG | 1 |
| Stewart, JS | 1 |
| Skånberg, J | 1 |
| Lugtenburg, PJ | 1 |
| De Jong, FH | 1 |
| Christiansen, A | 1 |
| Kam, BL | 1 |
| De Herder, WW | 1 |
| Stridsberg, M | 1 |
| Lindemans, J | 1 |
| Ensing, G | 1 |
| Ballou, JE | 1 |
| Dagle, GE | 1 |
| McDonald, KE | 1 |
| Buschbom, RL | 1 |
| Oei, HY | 1 |
| Barzen, G | 1 |
| Ochi, K | 1 |
| Fujii, T | 1 |
| Kimura, Y | 1 |
| Akamune, A | 1 |
| Hamamoto, K | 2 |
| Hofland, LJ | 1 |
| Marbach, P | 1 |
| Pralet, D | 1 |
| Stolz, B | 1 |
| Koper, JW | 1 |
| Erlemann, R | 1 |
| Stöber, U | 1 |
| Drews, C | 1 |
| Böcker, D | 1 |
| Peters, PE | 1 |
| Hnatowich, DJ | 3 |
| Sandring, KH | 1 |
| Lüning, M | 1 |
| Rosenstraus, MJ | 1 |
| Davis, WL | 1 |
| Lopes, AD | 1 |
| D'Aleo, CJ | 1 |
| Gilman, SC | 1 |
| Fletcher, BD | 1 |
| Hanna, SL | 1 |
| Chu, TM | 1 |
| Itai, Y | 1 |
| Hicks, RJ | 1 |
| Kalff, V | 1 |
| Brazenor, G | 1 |
| Rahmat, H | 1 |
| Kelly, MJ | 1 |
| Keenan, AM | 1 |
| Harbert, JC | 1 |
| Larson, SM | 1 |
| Prayer, L | 1 |
| Imhof, H | 1 |
| Stiglbauer, R | 1 |
| Kramer, J | 1 |
| Wimberger, D | 1 |
| Snook, D | 1 |
| Rowlinson, G | 1 |
| Stewart, S | 1 |
| Epenetos, AA | 1 |
| Tanada, S | 1 |
| Mogami, H | 1 |
| Mochizuki, T | 1 |
| Miyagawa, M | 1 |
| Yasuhara, Y | 1 |
| Iio, A | 1 |
| Zuckier, LS | 1 |
| Weissmann, HS | 1 |
| Kaplun, L | 1 |
| Schlossberg, I | 1 |
| Gade, MF | 1 |
| Freeman, LM | 1 |
| Happ, J | 1 |
| Baum, RP | 1 |
| Frohn, J | 1 |
| Weimer, B | 1 |
| Halbsguth, A | 1 |
| Lochner, B | 1 |
| Brandhorst, I | 1 |
| Hör, G | 1 |
| Quadri, SM | 1 |
| Wessels, BW | 1 |
| Griffin, TW | 1 |
| Kosciuczyk, C | 1 |
| Rusckowski, M | 1 |
| Childs, RL | 1 |
| Mattis, JA | 1 |
| Shealy, D | 1 |
| Doherty, PW | 1 |
| Sørensen, JB | 1 |
| Groth, S | 1 |
| Hansen, SW | 1 |
| Nissen, MH | 1 |
| Rørth, M | 1 |
| Hansen, HH | 1 |
| Norwood, WD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors[NCT04790708] | 250 participants (Anticipated) | Interventional | 2018-07-02 | Recruiting | |||
| Molecular and Whole-body MR Imaging in Lymphomas[NCT02389101] | 21 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Uptake of 68Ga-DOTANOC in lymphoma expressed as SUVmax (NCT02389101)
Timeframe: Within 30 days prior to start of chemotherapy
| Intervention | Standardized Uptake Value (Median) |
|---|---|
| Lymphoma | 3.1 |
24 reviews available for pentetic acid and Neoplasms
| Article | Year |
|---|---|
Review: Deoxyglucose compounds labeled with isotopes different from 18-fuoride: is there a future in clinical practice?
Topics: Animals; Deoxyglucose; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; M | 2008 |
Radiometallated peptides for molecular imaging and targeted therapy.
Topics: Coordination Complexes; Humans; Metals; Neoplasms; Pentetic Acid; Peptides; Radiopharmaceuticals; Re | 2011 |
Radiolabelled peptides for oncological diagnosis.
Topics: Animals; Bombesin; Cholecystokinin; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Human | 2012 |
Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Topics: Heterocyclic Compounds; Humans; Indium Radioisotopes; Neoplasms; Octreotide; Pentetic Acid; Peptides | 2002 |
Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
Topics: Humans; Intercellular Signaling Peptides and Proteins; Neoplasms; Octreotide; Pentetic Acid; Peptide | 2002 |
The folate receptor as a molecular target for tumor-selective radionuclide delivery.
Topics: Animals; Biomarkers, Tumor; Carrier Proteins; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Ne | 2003 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Topics: Humans; Indium Radioisotopes; Iodine Radioisotopes; Neoplasms; Octreotide; Pentetic Acid; Radionucli | 1994 |
Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Topics: Humans; Indium Radioisotopes; Iodine Radioisotopes; Neoplasms; Octreotide; Pentetic Acid; Radionucli | 1994 |
The diagnostic utility of somatostatin receptor scintigraphy in oncology.
Topics: Amino Acid Sequence; Humans; Indium Radioisotopes; Molecular Sequence Data; Neoplasms; Octreotide; P | 1996 |
Diagnostic use of radiolabeled antibodies for cancer.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Humans; Indium Radioisotopes; Neop | 1995 |
[Tumor imaging in nuclear medicine].
Topics: Citric Acid; Gallium Radioisotopes; Gamma Cameras; Humans; Indium Radioisotopes; Neoplasms; Octreoti | 1996 |
Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview.
Topics: Humans; Indium Radioisotopes; Neoplasms; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radiophar | 1997 |
[Nuclear oncology with monoclonal antibodies and peptides].
Topics: Animals; Antibodies, Monoclonal; Humans; Indium Radioisotopes; Iodine Radioisotopes; Mice; Neoplasms | 1998 |
Gd-DTPA enhances uses for MR imaging of body.
Topics: Cardiomyopathies; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Musculoskeletal Di | 1990 |
Peptide receptor imaging and therapy.
Topics: Humans; Indium Radioisotopes; Neoplasms; Neuroendocrine Tumors; Octreotide; Oligopeptides; Pentetic | 2000 |
Chelated metal ions for therapeutic and diagnostic applications.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Chelating Agents; Humans; Isotope Labeling; Isotopes; Meta | 2001 |
[Radioimmunoscintigraphy: fundamentals (1)].
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Iodine Radioisotopes; Neoplasms; Organometallic | 1992 |
Radiolabeling antibodies via the cyclic anhydride of DTPA--experiences of 5 years.
Topics: Antibodies, Monoclonal; Humans; Isotope Labeling; Liver; Neoplasms; Pentetic Acid; Radionuclide Imag | 1990 |
[Magnetic resonance tomography of the whole body--methodology and clinical results].
Topics: Cardiovascular Diseases; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Neopla | 1990 |
Potential applications of monoclonal antibodies in cancer diagnosis and therapy.
Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Antibody Specificity; Antigens, | 1985 |
[MRI and MRS in the diagnosis of cancer].
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Gadolinium DTPA; Hemangioma, Cav | 1989 |
Monoclonal antibodies in nuclear medicine.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Epitopes; Genes, MHC Class II; Humans; Hybridoma | 1985 |
Preparation and use of DTPA-coupled antitumor antibodies radiolabeled with yttrium-90.
Topics: Animals; Antibodies, Monoclonal; Drug Carriers; Humans; Mice; Mice, Nude; Neoplasms; Pentetic Acid; | 1988 |
4 trials available for pentetic acid and Neoplasms
| Article | Year |
|---|---|
Technical Note: Correction for the effect of breathing variations in CT pulmonary ventilation imaging.
Topics: Abdomen; Four-Dimensional Computed Tomography; Humans; Lung; Motion; Neoplasms; Organotechnetium Com | 2018 |
Three-dimensional OctreoScan111 SPECT of abdominal manifestation of neuroendocrine tumours.
Topics: Abdominal Neoplasms; Carcinoid Tumor; Female; Humans; Image Processing, Computer-Assisted; Indium Ra | 1993 |
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.
Topics: Antibodies, Monoclonal; Avidin; Biotinylation; Bone Marrow; Chelating Agents; Heterocyclic Compounds | 1999 |
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasms; Neuroendocrine Tumors; | 2002 |
81 other studies available for pentetic acid and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
All-in-One Theranostic Platforms: Deep-Red AIE Nanocrystals to Target Dual-Organelles for Efficient Photodynamic Therapy.
Topics: Humans; Nanoparticles; Neoplasms; Organelles; Pentetic Acid; Photochemotherapy; Photosensitizing Age | 2022 |
Prolonged Circulating Lipid Nanoparticles Enabled by High-Density Gd-DTPA-Bis(stearylamide) for Long-Lasting Enhanced Tumor Magnetic Resonance Imaging.
Topics: Animals; Contrast Media; Gadolinium DTPA; Lipids; Liposomes; Magnetic Resonance Imaging; Mice; Neopl | 2022 |
Novel Strategy to Drive the Intracellular Uptake of Lipid Nanoparticles for Photodynamic Therapy.
Topics: Cell Line, Tumor; Edetic Acid; Humans; Lipids; Liposomes; Nanoparticles; Neoplasms; Pentetic Acid; P | 2023 |
Organic disulfide-modified folate carbon dots for tumor-targeted synergistic chemodynamic/photodynamic therapy.
Topics: Carbon; Cell Line, Tumor; Disulfides; Folic Acid; Glutathione; Humans; Hydrogen Peroxide; Nanopartic | 2023 |
Development of
Topics: Animals; Cell Line, Tumor; Cetuximab; ErbB Receptors; Immunoconjugates; Mice; Mice, Nude; Neoplasms; | 2023 |
Bi-DTPA, a potential CT-guided radiation sensitizer.
Topics: Humans; Neoplasms; Pentetic Acid; Radiation Tolerance; Radiation-Sensitizing Agents; Tomography, X-R | 2023 |
Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future Perspectives.
Topics: Animals; Binding Sites; Humans; Immunoconjugates; Isotope Labeling; Ligands; Magnetic Resonance Imag | 2020 |
Whole cancer-region enhancement using meglumine-gadopentetate-glucose solution and 7.0-T magnetic resonance imaging.
Topics: Contrast Media; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Meglumine; Neoplasms; | 2021 |
Development of human serum albumin conjugated with near-infrared dye for photoacoustic tumor imaging.
Topics: Animals; Cell Line, Tumor; Female; Humans; Indium Radioisotopes; Indocyanine Green; Mice; Mice, Inbr | 2014 |
LAT1 targeted delivery of methionine based imaging probe derived from M(III) metal ions for early diagnosis of proliferating tumours using molecular imaging modalities.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Early Detection of Cancer; Fe | 2015 |
Development and Characterization of the Recombinant Human VEGF-EGF Dual-Targeting Fusion Protein as a Drug Delivery System.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Delivery Sy | 2015 |
Enhanced Delivery of Plasmid Encoding Interleukin-12 Gene by Diethylene Triamine Penta-Acetic Acid (DTPA)-Conjugated PEI Nanoparticles.
Topics: Cell Proliferation; Gene Transfer Techniques; Genetic Vectors; Hep G2 Cells; Humans; Hydrophobic and | 2016 |
Feasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imaging.
Topics: Animals; Cell Line, Tumor; Coloring Agents; Drug Carriers; Indium Radioisotopes; Indocyanine Green; | 2016 |
Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Indium Radioisotop | 2016 |
An Activatable Fluorescent γ-Polyglutamic Acid Complex for Sentinel Lymph Node Imaging.
Topics: Animals; Dendrimers; Fluorescence; Fluorescent Dyes; Humans; Lymphatic Metastasis; Lysosomes; Male; | 2017 |
Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Indium Radioisotopes; L | 2009 |
Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia.
Topics: Hemangioma; Humans; Hypophosphatemia; Indium Radioisotopes; Male; Middle Aged; Neoplasms; Octreotide | 2009 |
Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Topics: Adult; Aged; Animals; Biological Transport; Cell Line, Tumor; Chelating Agents; Drug Stability; Fema | 2010 |
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transform | 2010 |
Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma.
Topics: Animals; Antibodies, Monoclonal; Area Under Curve; Biological Transport; Cell Line, Tumor; Cell Tran | 2010 |
Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.
Topics: Animals; Chlorocebus aethiops; COS Cells; Humans; Mice; Mice, Nude; Models, Molecular; Neoplasms; NI | 2010 |
Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Topics: Animal Structures; Animals; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cysteine; Dru | 2010 |
Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.
Topics: Animals; Binding Sites; Cell Line; Chelating Agents; Fluorescent Dyes; Heterocyclic Compounds, 1-Rin | 2011 |
Noninvasive imaging of cell death using an Hsp90 ligand.
Topics: Animals; Arsenicals; Carbocyanines; Carcinoma, Lewis Lung; Cell Death; Colorectal Neoplasms; HSP90 H | 2011 |
Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; ErbB Receptors; Humans; Mice; Mice, Nude; Neoplasms; P | 2011 |
Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
Topics: Animals; Drug Delivery Systems; Humans; Neoplasms; Octreotide; Pentetic Acid; Peptides; Positron-Emi | 2011 |
A comparative study of two novel nanosized radiolabeled analogues of methionine for SPECT tumor imaging.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colon; Colonic Neoplasms; Dendrimers; Humans; Methionine; | 2013 |
Tumor targeting of gene expression through metal-coordinated conjugation with dextran.
Topics: Animals; Chelating Agents; Dextrans; DNA; Electrophoresis; Gene Expression Regulation, Neoplastic; G | 2003 |
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Topics: Adult; Aged; Edetic Acid; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasms; Octreo | 2003 |
PROGRESS REPORT: PLUTONIUM REMOVAL, TUMOR INCIDENCE STUDIES. III. ANL-6723.
Topics: Bone and Bones; Chelating Agents; Cohort Studies; Metabolism; Mice; Neoplasms; Neoplasms, Experiment | 1963 |
PROGRESS REPORT: PLUTONIUM REMOVAL. TUMOR INCIDENCE STUDIES. V. ANL-6823.
Topics: Animals; Bone Neoplasms; Chelating Agents; Cohort Studies; Injections, Intravenous; Mice; Neoplasms; | 1964 |
Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninvasive imaging of tumor apoptosis.
Topics: Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Humans; Neoplasms; Pentetic Acid; Polyethylene Gly | 2003 |
Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Drug Delivery Systems; Genetic Vectors; Immunoglo | 2003 |
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Drug Screenin | 2004 |
The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Indiu | 2004 |
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy.
Topics: Animals; Cell Line, Tumor; Indium Radioisotopes; Neoplasms; Oligopeptides; Pentetic Acid; Peptides, | 2004 |
Biodistribution data from 100 patients i.v. injected with 111In-DTPA-D-Phe1-octreotide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Indium Radioisotopes; Injections, Intrav | 2004 |
Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings.
Topics: Adult; Aged; DNA; Female; Humans; Indium; Indium Radioisotopes; Liver; Liver Neoplasms; Magnetic Res | 2005 |
Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.
Topics: Animals; Carrier Proteins; Folate Receptors, GPI-Anchored; Humans; Indium Radioisotopes; KB Cells; M | 2005 |
Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate.
Topics: Animals; Bone Marrow; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dimerization; Electrop | 2005 |
Auger electrons: lethal, low energy, and coming soon to a tumor cell nucleus near you.
Topics: Animals; Cell Nucleus; Electrons; Endocytosis; Humans; Indium Radioisotopes; Neoplasms; Pentetic Aci | 2005 |
Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fructose; Humans; Indium Radioisotop | 2006 |
Medicinal chemistry of somatostatin analogs leading to the DTPA and DOTA conjugates of the multi-receptor-ligand SOM230.
Topics: Chelating Agents; Heterocyclic Compounds, 1-Ring; Humans; Hydroxyproline; Isotope Labeling; Neoplasm | 2005 |
Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Cobalt Radioisotopes; Contrast Media; Excipients; Fulle | 2007 |
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.
Topics: Adult; Aged; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplast | 2007 |
Paramagnetic pharmaceuticals for magnetic resonance imaging.
Topics: Abdomen; Adult; Animals; Brain; Contrast Media; Deferoxamine; Electron Spin Resonance Spectroscopy; | 1984 |
The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies.
Topics: Abdominal Neoplasms; Animals; Brain Neoplasms; Colonic Neoplasms; Contrast Media; Edetic Acid; Ferri | 1984 |
[Survey on adverse reactions to radiopharmaceuticals: Report No. 3 (the 6th survey in 1980)].
Topics: Adolescent; Adosterol; Adrenal Glands; Adult; Aged; Child; Female; Gallium Radioisotopes; Hippurates | 1982 |
Magnetic resonance imaging of the lacrimal drainage system.
Topics: Abscess; Adult; Aged; Aged, 80 and over; Child; Female; Gadolinium DTPA; Humans; Lacrimal Apparatus; | 1994 |
A distributed pharmacokinetic model of two-step imaging and treatment protocols: application to streptavidin-conjugated monoclonal antibodies and radiolabeled biotin.
Topics: Bacterial Proteins; Biotin; Humans; Indium Radioisotopes; Models, Theoretical; Neoplasms; Pentetic A | 1993 |
Distribution and elimination of the somatostatin analogue (111In-DTPA-D-Phe1)-Octreotide (OctreoScan111).
Topics: Adenoma, Islet Cell; Adult; Aged; Carcinoid Tumor; Chromatography, Gel; Endocrine Gland Neoplasms; F | 1993 |
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Humans; In Vitro Techniques; Indium Radioisotopes; | 1996 |
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
Topics: Antineoplastic Agents; Area Under Curve; Carboplatin; Chromium Radioisotopes; Female; Glomerular Fil | 1996 |
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
Topics: Animals; Autoradiography; Cholecystokinin; Female; Humans; Indium Radioisotopes; Neoplasms; Pentetic | 1998 |
Experiences with high dose radiopeptide therapy: the health physics perspective.
Topics: Aged; Female; Guidelines as Topic; Half-Life; Health Physics; Humans; Indium Radioisotopes; Iodine R | 1999 |
Enhanced MRI fills in soft tissue features.
Topics: Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Pentet | 1991 |
Evaluation of three gamma detectors for intraoperative detection of tumors using 111In-labeled radiopharmaceuticals.
Topics: Cadmium Compounds; Cesium; Evaluation Studies as Topic; Gamma Rays; Humans; Indium Radioisotopes; In | 1999 |
Comparison between transversal SPECT, 3-dimensional rendering and 3-dimensional rendering plus clipping in the diagnosis of somatostatin receptor distribution in malignancies using 111In-DTPA-D-Phe1-octreotide scintigraphy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasms; Octreotide | 1997 |
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
Topics: Animals; Antineoplastic Agents; Autoradiography; Chromatography, High Pressure Liquid; Humans; Immun | 2000 |
Single-cell cytotoxicity with radiolabeled antibodies.
Topics: Antibodies, Monoclonal; Antigen-Antibody Complex; Antigens, Differentiation, B-Lymphocyte; Cytotoxic | 2001 |
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.
Topics: Drug Delivery Systems; Humans; Indium Radioisotopes; Liposomes; Neoplasms; Pentetic Acid; Radionucli | 2001 |
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
Topics: Adult; Aged; Drug Carriers; Drug Delivery Systems; Drug Stability; Female; Humans; Indium Radioisoto | 2001 |
Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Intraoperative Care; Male; Middle Aged; | 2001 |
Influence of inhaled Ca-DTPA on the long-term effects of inhaled Pu nitrate.
Topics: Aerosols; Animals; Body Weight; Bone Neoplasms; Calcium; Dose-Response Relationship, Drug; Dose-Resp | 1977 |
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Topics: Adult; Aged; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Neoplasm | 1992 |
[Potential application of DTPA for improving the image quality in radioimmunoscintigraphy with 111In labeled monoclonal antibodies].
Topics: Animals; Indium Radioisotopes; Liver; Male; Neoplasms; Pentetic Acid; Protein Binding; Radioimmunode | 1992 |
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
Topics: Amino Acid Sequence; Animals; Female; In Vitro Techniques; Indium Radioisotopes; Isotope Labeling; M | 1991 |
Favorable results in cancer imaging and therapy using monoclonal antibodies.
Topics: Antibodies, Monoclonal; Humans; Neoplasms; Oligopeptides; Pentetic Acid; Radioisotopes; Radionuclide | 1991 |
[Contrasts in the FLASH sequences in the study of musculoskeletal tumors: phantom study and theoretical calculations].
Topics: Bone Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mod | 1991 |
Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Carbohydrates; Carcinoembryonic Antigen; Dose | 1990 |
Musculoskeletal neoplasms: dynamic Gd-DTPA-enhanced MR imaging.
Topics: Bone Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Muscular Diseas | 1990 |
The radionuclide assessment of a system for slow intrathecal infusion of drugs.
Topics: Aged; Analgesics, Opioid; Equipment Failure; Evaluation Studies as Topic; Humans; Infusion Pumps; In | 1989 |
[Gadolinium-DTPA in magnetic resonance tomography. Clinical use--indications].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Child; Contrast Media; | 1989 |
[Clinical studies of radionuclide angiography with a new radioactive tracer, 99mTc-DTPA-human serum albumin].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Neoplasms; Organometallic Compounds; Pentetic Acid; | 1988 |
Significance of skeletal uptake detected on radionuclide renal perfusion studies.
Topics: Bone and Bones; Bone Diseases; Bone Marrow; Humans; Kidney Diseases; Male; Middle Aged; Neoplasms; O | 1987 |
[Immunoscintigraphy using 111In-DTPA-labeled monoclonal antibodies: comparison with ECT and planar scintigraphy].
Topics: Adult; Aged; Antibodies, Monoclonal; Humans; Middle Aged; Neoplasms; Pentetic Acid; Radionuclide Ima | 1987 |
Radiolabeled biomolecules with 186Re: potential for radioimmunotherapy.
Topics: Antibodies, Monoclonal; Humans; Indicators and Reagents; Neoplasms; Pentetic Acid; Radioisotopes; Rh | 1986 |
Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigen-Antibody Complex; Antigens, Neoplasm; Antigens, Tumor-A | 1985 |
Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056).
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Iodohippuric Acid; Kidney Tubules; Leukopenia; Male; M | 1985 |
Plutonium ( 239 Pu) toxicity diagnosis and therapy.
Topics: Accidents, Occupational; Animals; Chemical Phenomena; Chemistry; Dogs; Environmental Exposure; Feces | 1972 |